Want to see HK:2877 full AI Analyst Report?
China Shineway Pharmaceutical Group Limited (2877) Financial Statements
China Shineway Pharmaceutical Group Limited Financial Overview
China Shineway Pharmaceutical Group Limited's market cap is currently $5.67B. The company's EPS TTM is $1.05; its P/E ratio is 6.00; and it has a dividend yield of 16.85%. China Shineway Pharmaceutical Group Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.14B | $ 3.78B | $ 4.52B | $ 3.95B | $ 3.22B |
| Gross Profit | $ 2.27B | $ 2.83B | $ 3.39B | $ 2.94B | $ 2.41B |
| Operating Income | $ 682.07M | $ 842.60M | $ 975.53M | $ 713.58M | $ 534.37M |
| EBITDA | $ 752.95M | $ 904.73M | $ 1.42B | $ 1.10B | $ 903.74M |
| Net Income | $ 949.95M | $ 840.05M | $ 969.51M | $ 722.77M | $ 556.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.57B | $ 6.49B | $ 5.91B | $ 5.05B | $ 4.21B |
| Total Assets | $ 10.78B | $ 10.04B | $ 9.57B | $ 8.23B | $ 7.20B |
| Total Debt | $ 335.05M | $ 346.53M | $ 301.33M | $ 7.44M | $ 14.91M |
| Net Debt | $ -6.86B | $ -5.79B | $ -5.59B | $ -5.02B | $ -4.19B |
| Total Liabilities | $ 2.72B | $ 2.57B | $ 2.54B | $ 1.85B | $ 1.30B |
| Stockholders' Equity | $ 8.07B | $ 7.47B | $ 7.03B | $ 6.38B | $ 5.90B |
| Cash Flow | |||||
| Free Cash Flow | $ 974.13M | $ 823.02M | $ 788.31M | $ 980.21M | $ 609.52M |
| Operating Cash Flow | $ 1.17B | $ 963.13M | $ 932.63M | $ 1.11B | $ 703.15M |
| Investing Cash Flow | $ 222.03M | $ -272.11M | $ -49.54M | $ -45.42M | $ 395.01M |
| Financing Cash Flow | $ -375.01M | $ -392.48M | $ -26.74M | $ -250.04M | $ -828.93M |
Currency in CNY
